Influenza Vaccination in Children with Risk Conditions: The Missing Data and Solutions

Public health authorities in Spain have documented an increase in influenza vaccination coverage among young children following universal funding policies, but a persistent data gap remains for pediatric patients with underlying health conditions, analesdepediatria.org reported on April 30, 2026. The Advisory Committee on Vaccines and Immunizations of the Spanish Association of Pediatrics released a report showing that mean coverage for children aged one to five reached 52.3% during the 2025–2026 season, up from 37.2% in the 2023–2024 season.

Despite the broader population gains since public funding began across every autonomous community, health officials still lack specific surveillance data for children with risk conditions. Published case series estimate that vaccination coverage within this vulnerable pediatric subgroup ranges between 15% and 25%, indicating that many high-risk children remain unprotected despite being prioritized for immunization.

Surveillance Barriers and Missing Pediatric Data

The lack of precise data stems from structural limitations in current public health monitoring systems. The Vaccination Information System of the Ministry of Health of Spain reports coverage figures for the one-to-five age bracket as a single homogeneous population without stratifying the data by underlying medical conditions. According to analesdepediatria.org, the absence of a unified nationwide register, standardized methodologies, and reliable denominators prevents accurate tracking.

This blind spot is driven by three mutually reinforcing factors. Administrative case ascertainment is difficult because pediatric risk conditions are clinically heterogeneous, fluctuate over time, and utilize different diagnostic coding schemes across care levels, such as the International Classification of Primary Care and the International Classification of Disease. Healthcare fragmentation further isolates patient records between primary care teams and hospital specialists. Finally, neither national nor regional authorities have established specific vaccination coverage targets or indicators for pediatric risk groups.

Clinical Risks for Vulnerable Pediatric Patients

The consequences of low coverage in high-risk children are clinically significant. Severe influenza disproportionately affects pediatric patients with underlying health problems, driving up rates of hospital admission, medical complications, disease decompensation, and mortality. Data from a Spanish study cited by analesdepediatria.org revealed that up to 45% of children hospitalized for influenza had an underlying risk condition indicating a need for vaccination, and 74% of those hospitalized children were unvaccinated.

Those figures highlight a major shortfall in the prevention system, particularly given that vaccination for under-18 risk groups has been publicly funded for years. Extending routine immunization schedules through age 17 offers a fresh opportunity to capture missed patients, provided healthcare providers bridge the administrative divides that leave high-risk children unidentified.

Proposed Action Plan for the Upcoming Season

To correct these coverage failures, the pediatric advisory report outlines seven prioritized lines of action for the upcoming influenza season. These solutions target clinical, organizational, and public health levels to resolve case ascertainment issues and improve access for families managing chronic conditions.

• Creating personally identifiable patient registries at the start of the season that are shared between primary care and hospital settings, complete with electronic health record alerts.
• Providing active recommendations and unified messaging from physicians, nurses, and pharmacists.
• Aligning professional training across scientific societies, health authorities, and patient associations.
• Involving community pharmacies in routine medication dispensing to recommend vaccination.
• Issuing direct reminders to families of chronic patients.
• Improving vaccine accessibility through school-based programs, extended hours, and the availability of intranasal vaccines for eligible children aged two to 17.
• Communicating vaccination coverage results systematically to professionals and the public.

Autonomous communities and the Ministry of Health must establish specific coverage indicators and differentiated targets for this subgroup to ensure these strategies are implemented before the next immunization campaign begins in October.